|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/60 | (2017.01) |
| A61K 38/27 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 5/06 | (2006.01) |
| (11) | Number of the document | 3653227 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19214864.1 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2020-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (30) | Number | Date | Country code |
| 14193603 | 2014-11-18 | EP |
| (72) |
Kurpiers, Thomas, DE
Rau, Harald, DE
Exner, Evelyn, DE
Jensen, Steen, DK
Rasmussen, Grethe Norskov, DK
Lessmann, Torben, DE
Wegge, Thomas, DE
Hermann, Alina, DE
Schubert, Nina, DE
Splanemann, Anna, DE
Zettler, Joachim, DE
|
| (73) |
ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S,
Tuborg Boulevard 12, 2900 Hellerup,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nauji polimeriniai hGH provaistai |
| NOVEL POLYMERIC HGH PRODRUGS |
| Payment date | Validity (years) | Amount | |
| 2025-11-06 | 11 | 289.00 EUR |
| 2026-11-17 |